Antisoma PLC To Present At Rodman And Renshaw Healthcare Conference On November 8

2 November 2006, London, UK - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces that its Chief Executive Officer, Glyn Edwards, will be presenting at the Rodman & Renshaw 8th Annual Global Healthcare Conference in New York on Wednesday 8 November.

MORE ON THIS TOPIC